The market performance of Allogene Therapeutics Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $3.78 on 02/19/25, with the lowest value for the same timeframe being $1.09, recorded on 05/13/25. 52-week price history of ALLO Stock Analyzing
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -39.91% this year. Over the last six months, there has been
Allogene Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $3.78 on 02/19/25, while the lowest value for the same period was recorded at $1.23 on 04/09/25. 52-week price history of ALLO Stock A stock’s
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease
Allogene Therapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $3.78 on 02/19/25, while the lowest price for the same duration was marked at $1.23 on 04/09/25. 52-week price history of ALLO Stock
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Allogene Therapeutics Inc’s current trading price is -68.24% away from its 52-week high, while its distance from the 52-week low is 3.85%. The stock’s price
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -34.04%. However, over the last six months,
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Allogene Therapeutics Inc’s current trading price is -66.09% away from its 52-week high, while its distance from the 52-week low is 18.94%. The stock’s price
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -20.66%.However, over the last six months, we can see a
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a loss of -11.74%.However, over the last six months, we can
All rights reserved © 2024, Powered By Smart TechOne
